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Fresh normal serum treated  with immune complexes is chemotactic for polymor- 
phonudear leukocytes (PMN's) from a variety of species  (1, 2). The factor in treated 
serum causing specific directional migration of PMN's has been identified as a molec- 
ular complex consisting of the fifth  (C'5),  sixth  (C~6), and probably seventh  (CtT) 
components of complement (2, 3). 
The manner by which the chemotactic factor causes migration of leukocytes has 
proved difficult to  analyze and  is  virtually  unknown.  The major difficulty in such 
analysis  stems from the obvious requirement  for living,  intact ceils.  Previous work 
on  the  antigen-antibody-induced  release  of  histamine  from  tissue  slices  and  cell 
suspensions  has  dearly  demonstrated  that  organophosphorous  inkibitors  such  as 
diisopropylphosphofluoridate (DFP)  and phosphonate esters are particularly  suitable 
for the study of living cell systems (4).  These compounds inactivate a  specitic  group 
of enzymes, the serine esterases,  in a  characteristically irreversible manner  (5).  The 
p-nitrophenylethyl phosphonate esters have the general structure 
O 
Their inhibitory activity varies with changes in structure of the R group in a manner 
which is characteristic for such well defined esterases as trypsin, chymotrypsin, and 
acetylcholine esterase (5). There is also a characteristic variation in the relation of the 
structure of the phosphonate and its ability to inhibit the hemolytic activity of the 
first component of complement, C'la (4), and the antigen-induced release of histamine 
from sensitized slices of guinea pig lung (4),  and from rat peritoneal mast cells sensi- 
tized with rat homocytotropic antibody (6),  or with rabbit anti-rat ^/-globulin  (7). 
Because  of the well defined nature of the  inhibitory  activity of these phos- 
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phonates  and  the  relation  of  their  structure  to  the  specificity of  inhibition, 
they have  been  tested  for  their  effects  on  the  chemotaxis  of  PMN's  by the 
complement-dependent  chemotactic  factor.  Inhibition  of  chemotaxis  was 
found. The characteristics of such inhibition have led to the view that an ester- 
ase exists in or on the cell in a  phosphonate-insensitive, precursor form which 
is  transformed  directly  or  indirectly by  the  chemotactic  factor  into  a  phos- 
phonate-sensitive,  active  enzyme.  The  esterase  activated  in  this  manner  is 
required for the chemotactic response of the cell. In addition, it  would  appear 
that a  second esterase exists in or on the cell in an already activated  form,  i.e. 
susceptible to inhibition by certain phosphonate esters without the intervention 
of  the  chemotacfic  factor,  and  that  the  activity  of  this  second  "activated" 
esterase is also required for the chemotactic response of the cell. 
Materials and Methods 
Animals.--Housing and care of animals used as leukocyte and serum donors were provided 
by the Animal Care Branch of the Armed Forces Institute of Pathology. The "Principles of 
Laboratory Animal Care" as promulgated by the National Society for Medical Research were 
observed in these studies. 
Chemotaxis.--The system employing specially constructed stainless steel chambers with 
micropore filters (pore size 650 m/z) was used as previously described  (2). Chemotaxis of rab- 
bit polymorphonuclear leukocytes (PMN's)  which were  obtained from a  glycogen-induced 
peritoneal exudate was determined by counts of cell numbers after migration through micro- 
pore filters.  For most studies the period of chamber incubation, and thus cell migration, was 
60 rain. 
In previous experiments cell suspensions of rabbit PMN's for chemotactic studies were 
made up in 10% fresh rabbit serum (2). In the present study, it was found that cells were reac- 
tive when suspended in 0.5% ovalbumin (Nutritional Biochemical Corp., Cleveland, Ohio) 
in medium 199 at a pH of 7.4. All experiments were conducted with cells suspended in this 
albumin solution in order to obviate the problem of hydrolysis of phosphonate esters by an 
enzyme present in rabbit serum (8). 
The sources of the chemotactic factor used in the studies included: (a) the unpurified form 
present in 10% rabbit serum which had been treated with an immune precipitate (2); (b) a 
semipuritied form obtained by preparation of the active euglobulin  fraction from fresh rabbit 
serum treated with immune complexes and fractionation of the euglobulin on triethylamino- 
ethylceilulose (TEAE-cellulose); and (c)  the highly purified form of the  chemotactic factor 
obtained by fractionating the active TEAE-cellulose fraction in Pevikon block preparative 
electrophoresis.  The details of the procedure for obtaining the semipurified and highly purified 
preparations of the chemotactic factor have been described previously (2). 
The kind of preparation of the chemotactic factor used in the given experiment is indicated 
in the description of that experiment. As will be shown, the state of purity of the chemotactic 
factor does not influence the inhibitory effects of the phosphonates. 
Density Gradient Ultracentrifugation.--In density gradient experiments, 0.2  ml of highly 
purified chemotactic factor was added to sucrose density gradient solutions (10-40% sucrose 
at pH 7.3 or 8.6) and centrifuged at 35,000 rpm in a swinging bucket rotor for 20 hr as pre- 
viously described (2). Various fractions were analyzed for the sixth component of complement 
(C'6) and for chemotacfic activity (2). PETER A. WARD  AND  ELMER  L. BECKER  1003 
Phosphonate Inhibitors.--The  p-nitrophenylethyl phosphonates of  the general  structure 
O 
where R  represents the alkyl, phenylalkyl, ¢o-aminoalkyl, or ¢o-chloroalkyl  chain were used) 
They have been described previously (5). The phosphonate esters were dissolved in acetone 
diluted 1:10 or 1:100 (in medium 199 or appropriate phosphate buffer). The inhibitor under 
study was then appropriately diluted to a  final acetone concentration of 0.5%. Diisopropyl- 
phosphofluoridate (DFP),  kindly supplied by Dr. Bernard Jandorf, Army Chemical Corp., 
Edgewood, Md., was used in some studies. At the concentrations used DFP was readily soluble 
in medium 199 but acetone was added, for the purpose of control, in a final concentration of 
0.5%. 
Procedure for Demonstrating Inhibition.--Unless otherwise noted, two types of experimental 
procedures were used to determine the effects of the phosphonates on chemotaxis. The first 
procedure was designed to reveal the inhibitory effect of the phosphonate in the absence of 
the chemotactic factor. The cells,  at a  concentration of 2  X  106/ml, were preincubated at 
room temperature with an equal volume of phosphonate ester in medium 199.  All concen- 
trations of phosphonate esters were expressed as final concentrations after dilution with the 
cell suspensions. The cell suspensions contained 0.5% acetone. After an appropriate time of 
incubation, the cells were washed once with medium 199 to remove the inhibitor, centrifuged, 
and then resuspended in 0.5% ovalbumln. Control cells incubated with 0.5% acetone in me- 
dium 199 for the same length of time were carried through the same procedure, The response 
to the chemotactic factor of the cells pretreated with inhibitor compared to the response of 
the control cells was determined. The depressing effect of the phosphonate esters on cells in 
the absence of the chemotactic factor was termed call-dependent inhibition. 
The second type of procedure was designed to reveal any effect of the phosphonates on 
chemotaxis which was dependent upon the intervention of the chemotactic factor. The cells 
were incubated in medium 199 for 60 rain in the absence of phosphonate inhibitor. They were 
washed once, and centrifuged precisely as described in the procedure to measure cell-dependent 
inhibition, but then resuspended in the appropriate phosphonate ester. The cells suspended 
in inhibitor were immediately placed in chambers and the chemotactic response measured 
after a  60 rain period. The chemotactic responsiveness was also determined for control ceils 
treated in exactly the same way except that they were resuspended in 0.5% acetone in me- 
dium 199 instead of inhibitor. The reduction in response to the chemotactic factor of the cells 
suspended in inhibitor compared to the control cells was  termed the chemottwtic flwtor-de- 
pendent inhibigon. 
Usually cell-dependent and chemotactic factor-dependent inhibition were determined in 
the same experiment under conditions where the same batch of cells was in contact with the 
same concentration of the inhibitor for the same length of time. If, under a given set of experi- 
mental  conditions,  cell-dependent  inhibition was  demonstrable,  the  chemotactic  factor- 
dependent inhibition obtained was due either wholly or in part to the effect of the phosphonate 
on the cell alone. However, as will be described, under certain circumstances, no cell-dependent 
inhibition was obtained. One  could then speak of a  "true"  or  "pure" chemotactic factor- 
dependent inhibition. 
1 In what follows,  the p-nitrophenylethyl phosphonates will be named only according to 
the nature of the R  group, the presence of the p-nitrophenoxy and ethoxy groups being im- 
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Trypan B~e Studies.--In order to determine if generalized damage to the polymorpho- 
nuclear leukocytes was produced by contact with phosphonate esters, the following experi- 
ment was carried out. Leukocytes were incubated with three phosphonate esters at concen- 
trations sufficient to cause significant cell-dependent inhibition of chemotaxis. The details of 
this procedure were exactly the same as described above for the study of cell-dependent  chemo- 
taxis. After washing, the leukocytes were tested for their ability to respond to the chemotacfic 
factor. At the same time, a drop of the cell suspension was mixed with an equal volume of 
0.4% trypan blue dye (Matheson Scientific, Inc., Cincinnati, Ohio) in 80% rabbit  serum. 
After incubation at room temperature for 15 min, at least 100 ceils were examined by light 
microscopy and the per cent of stained cells determined. 
RESULTS 
Time Course of the Chemotactic Response.--In  order  to  study  the  possible 
inhibitory effects of phosphonate esters on the chemotactic response, it became 
necessary to define the time course of the response of the cells to the chemo- 
tactic factor in the absence of the inhibitor. In each of three experiments per- 
formed on different days, chemotaxis was measured after intervals of chamber 
incubation of 15, 30,  60,  and 90 rain. The source of the chemotactic factor was 
rabbit serum which had been incubated with immune complexes. The number 
of cells migrating  through  the falter at each interval was compared with  the 
value obtained at 90 rain, which was taken as the 100% value (Fig. 1). Within 
15 rain 25-34%  of cells responded,  and this figure more than doubled by the 
end of 30 rain. By 1 hr, the response was virtually completed, and only a few 
additional  cells were responding  at 90 rain.  In most of the following experi- 
ments, the 60 rain chemotactic response was selected in assessing inhibition by 
phosphonate esters. 
Kinetics  of Inhibition  of the Chemetactic Response.--12  of the phosphonate 
esters were used in defining the time course of inhibition of chemotaxis utilizing 
activated rabbit serum as the source of the chemotactic factor. Representative 
results obtained with four phosphonates in both cell-dependent and chemotac- 
tic factor-dependent inhibition  are given in Fig.  2.  The curves of inhibition 
are expected to be a function of the concentration of the inhibitor; nevertheless 
any  one  inhibitor  was  studied  at  only one  concentration.  With  the  propyl 
phosphonate and 5-aminopentyl phosphonate at the concentrations used it is 
evident  that  progressive  chemotactic  factor-dependent  inhibition  was  ob- 
tained  in  essentially  the  complete  absence  of  any  cell-dependent  inhibition 
(Fig.  2,  A  and D). With 5  X  10  -~ ~  phenyl phosphonate,  there was distinct 
cell-dependent inhibition, but the chemotactic factor-dependent inhibition was 
clearly greater at every interval tested  (Fig.  2,  C).  On the other hand,  with 
5-chloropentyl phosphonate at a concentration of 5.0 X  10  -4 ~, the time course 
of the two modes of inhibition was the same (Fig. 2, B). It is doubtful that the 
apparent lag in the course of inhibition over the first 15-30 min with 5-chloro- 
pentyl  phosphonate  and  the  propyl  phosphonate  is  real.  Repetition  of  the 
same  experiment  with  the  5-chloropentyl  phosphonate  did  not  reveal  any 
such lag. The same sort of lag was seen in a single experiment performed with PETER  A.  WARD  AND  ET.MER  L.  BECKER  1005 
the  phenyl phosphonate  and  pentyl phosphonate,  but  on repetition of  the 
experiment, no such lag was found. 
As  a  result  of these studies,  in  all subsequent  experiments cells  were uni- 
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FIO. 1. The time course of chemotactic activity. The 90 mln value was taken as the 100% 
value. Each experiment was performed on a  different day. 
formly placed in contact with each inhibitor for a 60 rain period, whether for 
the study of cell-dependent or chemotactic factor-dependent inhibition. 
Concentration Dependence of Phospkonate Inhibitors.wThe effect of the con- 
centration of phosphonate was determined for both cell-dependent and chemo- 
tactic factor-dependent inhibition. All experiments were duplicated at least 
once. The source of chemotactic factor included the partly purified prepara- 100~  INHIBITION 0]~ CHEMOTAXIS  BY  PHOSPHONATE  ESTERS 
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tion  as well as serum  which had been  treated with an immune precipitate. 
Inhibitors from each of the four available classes of phosphonate esters, alkyl, 
phenylalkyl, chloroalkyl,  and  aminoalkyl phosphonates  were  studied.  A  60 
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F~o.  3. The concentration dependence of inhibition of chemotaxis by phosphonates, The 
degree of inhibition is clearly a function of concentration of phosphonate. 
min incubation period was used. With a given inhibitor the same batch of cells 
was employed for both cell-dependent and chemotactic factor-dependent in- 
hibition. With all four inhibitors studied, phenylpropyl phosphonate, 4-chloro- 
butylphosphonate,  butyl phosphonate,  and  5-aminopentyl phosphonate,  the 
concentration  range  was  chosen  so  that  the  chemotactic  factor-dependent 
inhibition was greater than the cell-dependent inhibition. (Fig. 3, A-D). 
The requirement for a  minimal concentration of inhibitor before an effect 1008  INHIBITION  OF  CHEMOTAXIS  BY  PHOSPHONATE  ESTERS 
was discernible is dearly evident with most of the inhibitors in both cell-de- 
pendent and chemotactic factor-dependent inhibition. 
With the phenylpropyl phosphonate, the curves  of inhibition were closely 
parallel  and rose sharply and rapidly ill the dose range from 1.5 to 3  X  10  -4 
M (Fig. 3, A). 
With the other phosphonates shown  (Fig.  3,B,C,  and D),  there was no 
cell-dependent  inhibition evident over a fairly wide range of concentrations, 
even though chemotactic factor-dependent inhibition was clearly seen. In the 
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FIG. 4. The concentration dependence of inhibition of chemotaxis by diisopropylphospho- 
fluoridate (DFP). 
range of concentration in which both kinds of inhibition were obtainable, the 
degree of increase  in cell-dependent  inhibition with increasing  concentration 
of phosphonate was  less than in the case of the corresponding  chemotactic 
factor-dependent inhibition. 
Concentration Dependence of Znhibition by DFP.--Intfibifion  of chemotaxis 
by diisopropylphosphofluoridate  (DFP) was studied in order to compare with 
the inhibitory effects of the phosphonate esters reported above. It was evident 
that  both  types  of  inhibition  could  be  demonstrated with DFP,  but sub- 
stantially  higher  concentrations  were  required  when  compared  with  the 
phosphonates (Fig. 4). The dose of DFP required to produce 50 % chemotactic- 
factor-dependent inhibition was  7-20  times greater  than amounts of phos- 
phonate esters  giving comparable  inhibition (see Fig.  3).  As with the phos- PETER  A.  WARD  AND  ELMER  L.  BECKER  1009 
phonates, DFP gave distinct chemotactic factor-dependent inhibition at levels 
where no cell-dependent inhibition was detectable. 
Effect of Direct Contact  of Ckemotactic  Factor witk Pkospkonate Esters on its 
Ckemotactic  Acti~ty.--As is evident from Figs. 3 and 4, the organophosphorus 
inhibitors could induce chemotactic factor-dependent inhibition at concentra- 
tions of inhibitor where the cell-dependent inhibition was zero. The question 
then arose if, under this circumstance, the chemotactic factor-dependent inhi- 
bition was caused by the direct inactivation of the chemotactic factor by the 
phosphonate  ester.  For  this purpose  samples of partly purified chemotactic 
factor were incubated for 1 hr at 37°C with 1 ×  10  -~ M 4-chlorobutyl phos- 
phonate and with 1  X  10  -z M 5-~mln0pentyl phosphonate in 1:600 acetone, 
and with a  1:600 dilution of acetone in medium 199 as a  control. At the end 
TABLE I 
Lack of Dirett E~ezt of Pkospkonates on Chemotacti¢ Factor 
Material tested  Chemotactic value 
Blank (medium 199) 
200/~1 highly  purified  chemotactic  factor in acetone (1:600)* 
200 ~tl highly purified chemotactic  factor, incubated with 4-chiorobutyl 
phosphonate (1 X 10  -4 ~s) in acetone 1:600" 
200/d highly purified chemotaetic  factor, incubated with 5-~minopentyl 
phosphonate (1 X 10  ~  r0 in acetone 1:600" 
11 
107 
109 
117 
* Approximately 70/~g N protein incubated for I hr at 37°C, followed by overnight dialysis 
in medium 199. 
of the hr the mixtures were dialyzed overnight at 4°C to remove the inhibitor 
and then tested in the standard manner for their ability to induce chemotaxis 
of rabbit polymorphonuclear leukocytes. 
As can be seen in Table I, treatment of the chemotactic factor with either 
inhibitor had no effect on the activity of the factor. This was despite the fact 
that these inhibitors at the concentration used (1.0  X  10  -~ M) routinely give 
80-100 % chemotactic factor-dependent inhibition. 
A previous study has shown that the peptide, N-carbobenzoxyglutamyl-L- 
tyrosine inhibited  the  activity of chemotactic factor by dissociation of  the 
C'5,  C'6,  C'7 complex into its individual subunits (3).  This raised the possi- 
bility that the phosphonates might also inactivate the chemotactic factor by 
causing dissociation of the complex. The lack of any effect of phosphonates on 
the chemotactic factor observed in the preceding experiment might then be 
due to reassociation of the complex after removal of the phosphonate. In order 
to test this possibility the effect of the phosphonate on the chemotactic factor 
complex was tested directly by means of density gradient ultracentrifugation. 
Semipurified chemotactic factor (see Materials and Methods) was ultracen- 1010  INHIBITION  OF  CHEMOTAXIS  BY  PHOSPHONATE  ESTERS 
trifuged in sucrose density gradient.  In one sample,  1 X  10  -4 ~  4-chlorobutyl 
phosphonate in 0.5 %  acetone was present throughout the gradient; in another 
0.5 %  acetone alone was present.  Both of these gradients  were formed at pH 
pH 7.3 
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FIG. 5. The effect of 4-chlorobutyl phosphon&te on sedimentation of partly purified chemo- 
tactic factor in a sucrose density gradient. Neither the rate of sedimentation  nor the activity 
of the chemotactic factor is appreciably  altered  by the continued  presence of the inhibitor 
at a concentration which is highly inhibitory for ceUs. 
7.3.  A  third  sample  of the  chemotactic factor was centrifuged  at pH 8.6;  at 
this pH most of the complex dissociates (2, 3). After ultracentrifugation,  frac- 
tions were collected, diluted 1 : 10 in medium 199 or buffer solution, and tested 
for  C'6 hemolytic activity as well  as  chemotactic factor activity,  as  already 
described. 
The results are given in Fig. 5. In the sample in 0.5 % acetone (Fig. 5, middle PETER  A.  WARD  AND  ELM'F.R  L.  BECKER  1011 
frame), the C% had a bimodal distribution corresponding to the more rapidly 
sedimenting C'6 bound in the complex and the slower sedimenting,  unassoci- 
ated C'6.  The chemotactic factor activity was present in the more rapidly 
sedimenting fractions as expected on the basis of previous observations  (2). In 
the presence  of 1  X  10  -3 M 4-chlorobutyl phosphonate, the sedimentation be- 
havior of C'6 and of chemotactic factor activity was the same  (Fig.  5,  top 
frame). There was no evidence of any dissociation of the complex by the phos- 
phonate, despite the fact that the concentration of phosphonate used routinely 
gave high chemotactic factor-dependent inhibition. 
The control at pH 8.6 (Fig. 5, bottom frame) showed the anticipated disso- 
ciation of the trimolecular  (C'5,  C'6,  C'7)  complex. It was obvious  that no 
TABLE II 
E~ec~ of Phosphonates on PMN Response to HigMy Purified Chemotactic Factor 
llh~itor* 
Butyl 
4-chlorobutyl 
5-aminopentyl 
Phenylpropyl 
DFP 
Concentration 
H 
8X t0  ~ 
8X  10  -a 
5X 10-4 
3X 10  4 
3X 10  -a 
Per cent inh~ition of chemotactic 
response 
Cell dependent 
11 
29 
42 
31 
27 
Chemotactic factor 
dependent 
64 
78 
78 
65 
70 
* Added to cell suspensions. 
200 ~1 (approximately 70/~g N) highly purified chemotactic factor in medium 199. 
such dissociation of the complex occurred in the presence of the phosphonate 
inhibitor. 
Inhibition  of Chemolaxis by Pkosphonales Using Highly Purified Chemotacllc 
Factor.--In  several of the preceding experiments,  unpurified or partially puri- 
fied chemotactic factor had been used, raising the unlikely possibility that the 
chemotactic factor--dependent  inhibition might have been due to an interaction 
of the phosphonate with some constituent in the preparation other than the 
chemotactic factor. It was  therefore  deemed  necessary  to test the inhibitory 
action of a  representative group  of phosphonates on chemotaxis  induced by 
the  highly purified  factor.  Four phosphonates,  the butyl,  4-chlorobutyl,  5- 
aminopentyl, and phenylpropyl phosphonates,  and DFP were used.  Table II 
shows that these organophosphorus  ~nhlbitors caused the same general degree 
of ceU-dependent and chemotactic factor-dependent inhibition of the response 
to highly purified  chemotactic factor as  to the less purified  preparations of 
chemotactic factor. 
Profiles of Inhibition  of Chemotaxis by Phosphonates.--For each of the four 1012  INHIBITION  OF  CHEMOTAXIS  BY  PttOSPHONATE  ESTERS 
series of phosphonates  (alkyl, phenylalkyl, chloroalkyl, and aminoalkyl phos- 
phonates),  the  relationship  was  determined  between  the  length  of the  alkyl 
chain and the potency of the phosphonate in giving cell-dependent and chemo- 
¢/) 
X 
0 
1.1.1 
1" 
U 
h 
0 
:::,. 
0 
I-- 
"I- 
Z 
Z 
W 
U 
a. 
A. PHENYLALKYL PHOSPHONATE 
I00  ~~1 
80 
60  -Dependent 
5.0xlO-4M 
4o  I  C.e. otac,,c 
/.I  /  Factor-Dependent 
3.0 x 10-4M  20  i  ~" 
B. AMINOALKYL PHOSPHONATE 
Chemotactic 
80  Factor-Dependent 
1.5xlo-4M 
6o  \ 
40 
20 
0  I  I  I 
I  2  3 
C. ALKYL  PHOSPHONATE 
) Cell-Dependent 
4.0 x 10"4M 
k 
/  t 
~"  "t  /~  Chemotactic 
•  Factor-Dependent 
/  4.0xlO-4M 
D. CHLOROALKYL PHOSPHONATE 
Chemotacfic 
Factor-Dependent 
Cell-Dependent  / 
.OxK~4W 
I  I  I  I 
4  5  G 
3.0 X 1(~4M  ~.~ 
p./"  "~--/ 
i  ,~/Cel I-Dependent 
I 4"° x 10-4M 
I  2  3  4  5  6 
NUMBER OF CARBON ATOMS IN ALKYL CHAIN 
Fro. 6. Structure-activity relationships found for various phosphonates in ceU-dependent 
and chemotactic factor-dependent inhibition. Distinct and divergent patterns for the two types 
on inhibition are seen for each class of phosphonates except the phenylalkyl series. 
tactic factor-dependent inhibition.  All members of a  given series were tested 
at a single concentration of phosphonate. Because of the day to day variation 
in susceptibility of the leukocytes to the phosphonates,  a  single batch of cells 
was used each time a  series of phosphonates was compared. Activated serum 
served  as  the  source of chemotactic factor in  these  experiments.  When  the 
chemotactic factor-dependent inhibition was studied,  the concentration of the PETER  A.  WARD AND  ELMER  L.  BECKER  1013 
phosphonate was chosen to be low enough so that in that given experiment 
there was no cell-dependent inhibition. The lack of cell-dependent inhibition 
at the chosen concentration was demonstrated in the same experiment. This 
precaution was necessary in order that a "pure" chemotactic factor-dependent 
inhibition be obtained,  and not one which had superimposed cell-dependent 
inhibition. Each comparison was repeated at least once. 
Fig. 6 shows the results obtained. In the phenylalkyl series  (Fig. 6, A), the 
cell-dependent and chemotactic factor-dependent inhibition profiles were the 
same, as far as they could be tested. In the phenylalkyl series,  interposition 
of one carbon between the phenyl ring and the phosphorus to form the benzyl 
TABLE III 
Effect of Substitution of Chloro or Amino Groups  on the Activity of Alkyl Phosphonate3  in 
Inhibiting Chemotaxis 
Phosphonate 
Pentyl 
5-chloropentyl 
5-aminopentyl 
Hexyl 
6-chlorohexyl 
5-aminohexyl 
Inhibition of chemotaxis* 
Cell-dependent 
0 
63 
6 
96 
14 
25 
Chemotactic 
factor-dependent 
0 
55 
61 
93 
49 
77 
* Expressed as per cent reduction of response compared with untreated cells.  Activated 
rabbit serum (10%) was used as the source of chemotactic factor. As indicated in Materials 
and Methods, for cell-dependent inhibition PMN's were pretreated with the phosphonate 
inhibitors. For chemotacfic factor-dependent inhibition, the inhibitors were added to cells 
immediately before addition to chambers. 
phosphonate caused a  marked reduction in inhibitory capacities.  Increasing 
the chain length by one or two additional carbons resulted in increasing inhi- 
bition of both types (Fig. 6, A). The effectiveness of the phenylbutyl phospho- 
nate in chemotactic factor-dependent inhibition could not be studied since at 
any usable concentration it gave 100 % cell-dependent inhibition. In the ami- 
noalkyl phosphonates  (Fig.  6, B),  the change from the pentyl to  the hexyl 
compound resulted in different effects on the  two types of inhibition, there 
being a reduction in chemotactic factor-dependent inhibition and an enhance- 
ment of the cell-dependent inhibition. With the alkyl phosphonate series,  the 
butyl compound was most inhibitory for chemotacfic factor-dependent inhibi- 
tion, whereas the cell-dependent inhibition was strikingly increased going from 
the four or five carbon phosphonate to the six carbon hexyl phosphonate (Fig. 
6, C). In the chloroalkyl series it was found that chemotactic factor-dependent 1014  INHIBITION  OF CHEMOTAXIS BY PHOSPHONATE  ESTERS 
inhibition  was maximal  at  the four  carbon  chain,  with  a  slight  lessening  in 
inhibitory activities as the chain length increased to five and six carbons (Fig. 
6,D).  At  the  concentration  employed,  there  was  little  or  no  cell-dependent 
inhibition  in  the  chloroalkyl  series until  the  pentyl  and  hexyl phosphonates 
were reached (Fig. 6,D). 
Effect of the Substitution  of an Amino or Chloro  Group in the Alkyl Chain of 
the  Phosphonates.--The  pentyl  and  hexyl  phosphonates  and  their  o~-amino 
and oJ-chloro derivatives were  tested  at  the  same concentration  in  the  same 
TABLE IV 
Uptake of Trypan Blue in  Cells Inhibited by  Various Phosphonate3 
Inhibitor used 
5-chloropentyl 
Concentration 
"  "  4  X 
Hexyl  5 X 
3X 
2X 
1X 
Phenylbutyl  8 X 
6× 
4X 
None 
M 
6 X 10.4 
10-4 
lO-4 
Experiment  A 
Chemotaxis  Dye 
50  (68%)* 
0  (loo%) 
~ptake 
o, 
Experiment  B 
Chemotaxis90  (71%)  Dye ~take[ 
215  (31%) 
0  (100%)  95 
10.4  17  (95%) 
10-4 
10  ~ 
10  ~  30  (84%) 
10  4  7O  (53%) 
10-*  118  (16%) 
--  137 
5  (98%) 
106  (66%) 
203  (35%) 
160  (49%) 
230  (27%) 
310  0%) 
314 
34 
3 
0 
* Number of migrating cells determined by standard assay method. Figure in parenthesis 
refers to reduction of the chemotactic response by comparison to positive controls listed at 
the bottom of each vertical column. 
~t Per cent of cells (100 counted) with uptake of trypan blue. 
experiment for both cell-dependent and chemotactic factor-dependent inhibi- 
tion (Table In). The substitution of a chloro group for a terminal hydrogen in 
pentyl phosphonate resulted in a substantial increase in cell-dependent inhibi- 
tory capacity,  whereas,  the  substitution  of an  amino group had  little  or no 
effect. On the other hand,  the increase in chemotactic factor-dependent inhi- 
bition going from the pentyl to the chloropentyl phosphonate could be wholly 
accounted  for  by  the  superimposed  cell-dependent  inhibition.  The  latter, 
however, could not account for the effectiveness of the aminopentyl compared 
to the pentyl phosphonate. 
The cell-dependent inhibition given by the hexyl phosphonate was decreased 
to about the same extent when either the amino or chloro group was substi- PETER  A.  WARD  AND  ELMER  L.  BECKER  1015 
tuted.  The  high  cell-dependent  inhibition  made  the significance  of the high 
chemotactic factor-dependent inhibition given by the hexyl phosphonate im- 
possible to evaluate. This in turn made it impossible  to compare the effect of 
a substitution of the chloro or amino group in the hexyl phosphonate on chem- 
otactic factor-dependent inhibition. 
Trypan  Blue  Uptake by Leukocytes Treated with Phosphonate  Esters.--The 
exclusion  of the dye,  try-pan  blue,  was used to determine  the extent of cell 
damage after contact with three phosphonate esters (Table IV). The 5-chloro- 
pentyl,  hexyl,  and  phenylbutyl  phosphonates  were  used  in  concentrations 
which were known to produce significant  cell-dependent inhibition.  Incubation 
of leukocytes with the hexyl compound at the higher  concentrations (5 X  10  -~ 
and 3  X  10  ~  M) caused significant  uptake of trypan blue dye. However, at 
concentrations below 3  X  10  -~ M, no significant  uptake of the dye by leuko- 
cytes was noted  (3% of cells),  even though as much as 66% cell-dependent 
inhibition occurred. With the 5-chloropentyl and phenybutyl phosphonates as 
much  as  84%  cell-dependent  inhibition  occurred  in  the  absence of demon- 
strable uptake of the dye. As a  result of these experiments,  it became clear 
that  phosphonate-induced  cell-dependent inhibition  was not associated with 
generalized  cell damage  as  defined  by the ability of a  leukocyte to exclude 
trypan blue. 
DISCUSSION 
These  studies  have  clearly  established  that  phosphonate  esters  and  di- 
isopropylphosphofluoridate can inhibit  the chemotacfic response of polymor- 
phonuclear leukocytes to the complement-associated chemotactic factor. The 
action of these organophosphorus inhibitors is at least twofold. As is evident 
from what we term "cell-dependent inhibition"  there is a  direct,  irreversible 
action of the phosphonate on the cells. In addition to this,  there is a "chemo- 
tactic  factor-dependent  inhibition"  which  requires  the  interaction  of  the 
chemotactic factor and the leukocyte for its manifestation. 
The cell-dependent inhibition is progressive; the greater the length of time 
the cells are in contact with the inhibitor,  the greater the degree of inhibition 
(Fig.  2, A-D).  It is also irreversible: removing the cells from the organophos- 
phorus compound does not restore their ability to respond to the chemotactic 
factor. There is a distinct specificity of the inhibition  which is related to phos- 
phonate structure, as is evident from Fig. 6. All of these properties lead to the 
conclusion  that  a  cell-bound serine  esterase existing  in  an  already activated 
state is necessary for the chemotactic response.  Whether this already activated 
esterase exists  as such,  is activated during  the development of the glycogen- 
induced peritoneal exudate, or is activated by cells standing at room tempera- 
ture during the incubation with phosphonate, was not determined. 
The inhibition profiles given by the phenylalkyl, alkyl, and chloroalkyl phos- 1016  INHIBITION  O]~  CIIEMOTAXIS  BY  PHOSPHONATE  ESTERS 
phonates  in  the  system measuring  cell-dependent  inhibition  are  completely 
different from those obtained by the same three series of phosphonates reacting 
with chymotrypsin, trypsin, acetylcholine,  and C'la (5, 7). The inhibition pro- 
files  found  with  the  5-aminopentyl  and  6-aminohexyl  phosphonate  in  cell- 
dependent inhibition are dissimilar  to the inhibition profiles for Crla, trypsin, 
and acetylcholine but similar  to chymotrypsin (5). These dissimilarities  indi- 
cate that  the already activated esterase of the polymorphonuclear leukocyte 
which  is blocked by the  organophosphorus  inhibitors  is  none  of  these  well 
characterized  enzymes.  This  conclusion  is  substantiated  by  the  substrate 
specificity of the activated leukocyte enzyme reported in the next paper (9). 
The inhibition profiles given by these same four series of phosphonate esters 
when they are reacted with  the antigen-antibody-activated  esterases of the 
guinea pig lung (4) and the rat mast cell (6, 7) are distinctly different from the 
cell-dependent inhibition profiles. These differences indicate that the precursor 
enzymes of the mast cells of the rat and guinea pig are not the same as the al- 
ready activated esterase of the polymorphonuclear leukocyte. 
In  experiments  dealing  with  the  release  of histamine  from rat  peritoneal 
mast cells, an unexpected effect of certain of the phosphonate esters was found. 
At lower doses the phosphonate ester actually enhanced the release  of hista- 
mine. It was shown that the few phosphonates giving this behavior did  so by 
virtue of an impurity present in the preparations (6). Most of the phosphonates 
used here were those shown to be free of the impurity. The three compounds 
used which did contain the impurity,  the hexyl, 6-aminohexyl,  and 6-chloro- 
hexyl phosphonates, did not lead to any such anomalous results in the chemo- 
taxis  system.  Moreover,  the  results  of  substrate  protection  tests  using  the 
hexyl phosphonate showed that the inhibition obtained was due to the phos- 
phonate,  and not the impurity (9).  The rabbit polymorphonuclear leukocyte 
is apparently similar  to the sensitized  guinea pig lung in not being susceptible 
to the action of the impurity (4). 
Under some circumstances,  (Fig.  2, B), chemotactic factor-dependent inhi- 
bition can be completely accounted for by the inhibition of the activated es- 
terase of the leukocyte. This is clearly not the case in all  circumstanes.  Sig- 
nificant chemotactic factor-dependent inhibition can occur during a period of 
contact of cell with inhibitor (Fig.  2, A and D) or at a concentration of inhibi- 
tor (Fig. 3) where the cell-dependent inhibition is negligible or nonexistent. All 
the results shown in Fig. 6 on the specificity of the chemotactic factor-depend- 
ent  inhibition  were  at  concentrations  of phosphonates  where  no  significant 
cell-dependent  inhibition  was observed over  the  60  min  incubation  period. 
From Fig.  6 it is also clear that,  except for the phenylalkyl phosphonates, the 
inhibition profiles given by the cell-dependent and "pure" chemotactic factor- 
dependent inhibition are completely different. 
From these results, it is evident that  under  some  circumstances inhibition PETER A. WARD  AND  ELMER  L. BECKER  1017 
of chemotaxis  by  the  organophosphorus  compounds  can  occur  only in  the 
presence  of the chemotactic factor. A direct irreversible  action of the phos- 
phonate on  the chemotactic factor itself  was  eliminated by the experiment 
reported in Table I  in which the chemotactic factor was incubated with the 
phosphonates in the absence  of cells. The experiments  illustrated in Fig.  5 
showed that the phosphonates do not reversibly  dissociate  the C'5,  C%,  C'7 
complex and thus destroy its activity. 
In  "pure"  chemotactic factor-dependent inhibition there  is,  therefore,  a 
lack of any direct effect of the phosphonates  on the chemotactic factor or on 
the cell, but the chemotactic factor must interact with the cells in order for 
the inhibition to occur. Since the phosphonates are irreversible enzyme inhibi- 
tors, this implies that they inhibit by reacting with an esterase which has been 
activated by the chemotactic factor. This esterase exists in or on the leukocyte 
in a phosphonate-resistant precursor  form until activated by the chemotactic 
factor. The term "activatable" esterase will be used to describe this enzyme. 
The  chemotactic factor-dependent  inhibition profile given by the phenyl- 
alkyl phosphonates (Fig.  6)  is  the same  as  the profile of the cell-dependent 
inhibition reaction.  In work not reported here,  the phenylbutyl phosphonate 
was tested Over a  concentration range from 4  >(  10  -5 to 5  X  10  -6 ~  for its 
activity in cell-dependent and chemotactic factor-dependent inhibition. In this 
concentration range, the phenylbutyl phosphonate was slightly but consistently 
more reactive in chemotaetic factor-dependent inhibition than in cell-depend- 
ent inhibition.  This suggests that the phenylbutyl phosphonate at these  low 
concentrations may still be capable  of reacting with the enzyme which  has 
been rendered susceptible by the chemotactic factor to inhibition by the phos- 
phonate. If so,  this would make the phenybutyl phosphonate more reactive 
than the pheny]propyl phosphonate in chemotactic factor-dependent inhibi- 
tion, as well as cell-dependent inhibition. This conclusion is uncertain, however, 
since it was impossible to find a concentration of the phenylbutyl phosphonate 
in which there was a clearcut chemotactic factor-dependent inhibition in the 
absence of cell-dependent inhibition. 
The ehemotactic factor-dependent inhibition profiles given  by the amino- 
alkyl (Fig.  6, B), alkyl (Fig.  6,  C) and chloroalkyl  phosphonates  (Fig.  6, D) 
differ in almost every detail from the cell-dependent  inhibition profiles. The 
effect of substituting a chloro or amino group on the pentyl phosphonate on 
the ability of these phosphonates to give either cell-dependent or chemotacfic 
factor-dependent inhibition is  also  different (Table  HI).  These  differences 
make it clear that the esterase activated by the chemotactic factor is not the 
same  as  the  esterase  whose inhibition is  responsible  for the  cell-dependent 
inhibition. 
The esterase  of the polymorphonuclear  leukocyte activated by the chemo- 
tactic factor also differs from acetyl cholinesterase,  chymotrypsiu, and trypsin 1018  INHIBITION OF CHEMOTAXIS  BY PHOSPHONATE  ESTERS 
(4, 5). The inhibition  profiles given by the reactions of the alkyl phosphonates, 
and the two aminoalkyl phosphonates with Ctla and the activatable enzyme of 
chemotaxis  are  essentially  the  same  (4,  6).  However,  the  optimum  activity 
against C'la in the chloroalkyl phosphonate series is reached  by the 3-chloro- 
propyl phosphonate, whereas the peak activity against the activatable enzyme 
of chemotaxis  is given by the 4-chlorobutyl phosphonate (6). Moreover, in the 
phenylalkyl series the benzyl phosphonate has minimum activity against chemo- 
taxis,  but the phenylethylphosphonate is the least active against Cqa (7). 
The inhibition profile given by the reaction of the phenylalkyl phosphonates 
with  the  activatable enzyme of chemotoxis is  distinctly different from  that 
found when the same series of phosphonates inhibits the antigen-induced hista- 
mine release from sensitized  guinea pig lung (4). However, the changes in reac- 
tivity of esterase with phosphonate structure are similar when the responses of 
the  two biological  systems  to  the  chloroalkyl,  alkyl,  and  aminoalkyl  phos- 
phonates are compared (4). 
The  distinct  similarities  found  in  the  various  inhibition  profiles  indicate 
that the activatable enzyme of chemotaxis, Cqa, and the serine esterase acti- 
vated during  the antigen-induced release  of histamine from sensitized  guinea 
pig lung have a similar  although not identical specificity;  i.e., they are "para- 
zymes" (4). 
There is a much greater dissimilarity in the inhibition profiles given by the 
reaction of the phenylalkyl and chloroalkyl phosphonates with the activated 
esterase of chemotaxis,  and  the  esterase  involved in  the previously  studied 
allergic release of histamine from rat peritoneal mast cells (6, 7). 
The present work brings out a distinct resemblance between the chemotaxis 
of polymorphonuclear leukocytes induced by the chemotactic factor, and the 
release of histamine from rat and guinea pig mast cells induced by the antigen- 
antibody reaction (6, 7). In all cases, the activation of a precursor esterase is 
required for the specific response.  The possibility that  an  already activated 
esterase is also needed for the antigen-antibody-induced release  of histamine 
from guinea  and  rat  mast  cells has  not been investigated  under  conditions 
similar  to those used here. In view of the present findings in regard to the cell- 
dependent inhibition  of chemotaxis by phosphonates,  a  similar  study of the 
antigen-antibody-induced  release  of histamine  is indicated.  Lichtenstein and 
Osier (10) have already obtained cell-dependent inhibition by DFP of antigen- 
induced histamine release  from sensitized  human leukocytes. In this mode of 
histamine  release,  however, no evidence  for a precursor esterase could be ob- 
tained (10). This latter point also needs restudy. 
Finally, it is important to point out the data which emphasize  the specificity 
of inhibition  of chemotaxis by various phosphonate  esters.  The fact that no 
uptake of the dye trypan blue was found in leukocytes treated with phospho- 
nate esters under conditions resulting  in a high degree of cell-dependent inhi- PETER  A.  WARD  AND  ELMER  L.  BECKER  1019 
bifion indicates that the effect on the cells is not one of generalized cell damage. 
Cells so treated still retain the ability to exclude the dye. This is in keeping 
with the idea that the phosphonates inhibit cell responsiveness to the chemo- 
tactic factor by blocking a specific enzyme system. 
SUMMARY 
Studies in the time course of the response of rabbit polymorphonuclear leu- 
kocytes (PMN's)  to  the  complement-associated chemotactic factor have  re- 
vealed that the response is virtually complete by 60 rain with less than 15 % 
additionally responding cells thereafter. 
Phosphonate esters with a  well defined capacity to inhibit serine esterases 
have been used to study the cell-associated enzymes of the rabbit  PMN re- 
quired for the chemotactic response.  Two  types of inhibition of the cell  re- 
sponse to the chemotactic factor have been found: (a)  cell-depend~t  inhibition 
occurring as a result of pretreatment of PMN's with phosphonate esters; and 
(b) che~wtactic factor-dependent  inhibition  demonstrated only when the phos- 
phonate ester is present during the chemotactic response. 
Differences were found in these two modes of inhibition caused by various 
phosphonates, in terms of their time course of inhibition, in the dose response 
curves, and in the structure-activity relationships. 
It has been conclusively demonstrated that the phosphonate esters have no 
direct inhibitory effect on the chemotactic factor. This has been shown by re- 
tention of activity of the chemotactic factor following incubation with phos- 
phonate esters and subsequent removal by dialysis. In addition, the activity 
of the chemotactic factor and its physical-chemical characteristics in density 
gradient  ultracentrifugation were  unaltered  in  the  continued presence  of  a 
potent phosphonate inhibitor of chemotaxis. 
The uptake of the dye trypan blue was studied in cells treated with phos- 
phonate in such a manner to induce ceil-dependent inhibition of chemotaxis. 
Even when 84 %  cell-dependent inhibition of chemotaxis occurred, no uptake 
of the dye by leukocytes was found. Thus, phosphonate-induced inhibition of 
cell  responsiveness  in  chemotaxis  was  not  associated  with  generalized  cell 
damage as defined by exclusion of the dye. 
It is concluded that cell-dependent inhibition  is due to the presence of a cell- 
bound esterase which is already activated and thus susceptible to inhibition 
by phosphonate esters before contact of the cell with the chemotactic  factor. 
The second type of inhibition, chemotactic factor-dependent  inhibition,  is con- 
sidered due to a  cell-bound esterase which becomes susceptible to inhibition 
by phosphonate esters only after contact of the PMN with the chemotactic 
factor. It is postulated that the chemotactic factor activates this phosphonate- 
resistant precursor making it susceptible to the inhibitory action of the phos- 
phonate ester. 1020  INHIBITION  OF  CHEMOTAXIS BY  PHOSPHONATE ESTERS 
BIBLIOGRAPHY 
i.  Boyden, S. V. i962.  The chemotactic effect of mixtures of antibody and antigen 
on polymorphonuclear leukocytes.  Y. Exptl. ]fled.  115:453. 
2.  Ward, P. A., C. G. Cochrane, and H. J. MiiUer-Eberhard.  1965. The role of serum 
complement in chemotaxis of leukocytes in vitro. J. Exptl. Med. 19-9-:322. 
3.  Ward, P. A.,  C. G. Cochrane,  and H. J. Miiller-Eberhard.  1966. Further studies 
on the chemotactic factor of complement and its formation in rico. Immunology. 
11:141. 
4.  Becker, E. L., and K. F. Austen.  1964. A comparison of the specificity of inhibition 
by phosphonate esters of the first component of complement and the antigen- 
induced  release of histamine from guinea pig lung. J. Exptl. Med. 120:491. 
5.  Becker,  E. L., T. R. Fukuto, B. Boone,  D. C. Canham, and E. Boger. 1963. The 
relationship of enzyme inhibitory activity to the structure of n-alkyl phospho- 
hate and phenylalkyl phosphonate esters.  Biochemistry. 2:72. 
6.  Becker,  E. L., and K. F. Austen.  1966. Mechanisms of immunologic  injury of rat 
peritoneal mast cells. I. The effect of phosphonate inhibitors  on the homocyto- 
tropic  antibody mediated  histamine-release  and  the  first  component  of  rat 
complement. J. Exptl. Med. 124:379. 
7.  Austen, K. F., and E. L. Becker.  1966. Mechanisms of immunologic  injury of rat 
peritoneal  mast  cells. II.  Complement  requirement  and  phosphonate  ester 
inhibition of release of histamine by rabbit anti-rat gamma globulin. J. Exptl. 
Med.  124:397. 
8.  Becket, E. L., and J. F. Barbaro. 1964. The enzymatic hydrolysis of p-nitrophenyl 
ethyl phosphonates by mammalian plasmas. Biochem. Pharmacol. 13:1219. 
9.  Becker,  E. L., and P. A. Ward. 1967. Partial biochemical characterization of the 
activated esterase required  in the complement-dependent chemotaxis of rabbit 
polymorphonuclear leukocytes.  Y. Expg.  Meal. 125:1021. 
10.  Lichtenstein, L. M., and A. G. Osler. 1966. Studies  on the mechanisms of hyper- 
sensitivity phenomena. XI. The effect of normal human serum on the release 
of histamine from human leukocytes by ragweed  pollen  antigen.  J. Immunol. 
96:159. 